Mission Our Vision Fearlessly lead the way to create a world with better brain health.
Our Mission Pioneer solutions to deliver life-changing brain health medicines, so every person can thrive.
Description Sage Therapeutics is on a mission to pioneer solutions to deliver life-changing brain health medicines, so that every person can thrive. We believe that it is time to usher in a new era in how to think about and treat brain health disorders. It starts with our commitment to maternal mental health and our role in bringing the only FDA-approved treatments for postpartum depression to market. Through our pioneering science, we aim to address unmet needs of other brain health disorders, including essential tremor and cognitive impairment associated with certain neurodegenerative diseases. Integrating the patient and care partner perspectives into every aspect of our work, from research through to commercialization helps accelerate our impact. Our purpose is personal, and we see the potential to impact millions of people. Seeing the brain differently makes a world of difference. For more information, please visit us at SageRx.com or Careers.SageRx.com
Sage Therapeutics has an employee rating of 4.3 out of 5 stars, based on 186 company reviews on Glassdoor which indicates that most employees have an excellent working experience there. The Sage Therapeutics employee rating is 26% above average for employers within the Pharmaceutical & Biotechnology industry (3.4 stars).
Employees rate Sage Therapeutics 4.3 out of 5 stars based on 186 anonymous reviews on Glassdoor. In 2020, Sage Therapeutics employees have voted their company to be one of Glassdoor’s Best Places to Work.
Overall, 76% of employees would recommend working at Sage Therapeutics to a friend. This is based on 186 anonymously submitted reviews on Glassdoor.
75% of job seekers rate their interview experience at Sage Therapeutics as positive. Candidates give an average difficulty score of 3 out of 5 (where 5 is the highest level of difficulty) for their job interview at Sage Therapeutics.